Neurometabolite Levels in Alcohol Use Disorder Patients During Baclofen Treatment and Prediction of Relapse to Heavy Drinking

Background and Aims: Baclofen, a GABAB agonist, is used as a treatment for alcohol dependence. We aimed to examine brain metabolites following administration of baclofen or placebo in alcohol dependent individuals enrolled in a randomized placebo-controlled trial.Methods: Participants included 31 al...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Kirsten C. Morley, Jim Lagopoulos, Warren Logge, Kate Chitty, Andrew Baillie, Paul S. Haber
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Frontiers Media S.A. 2018-09-01
Sarja:	Frontiers in Psychiatry
Aiheet:	GABA glutamate GSH NAA baclofen alcohol dependence
Linkit:	https://www.frontiersin.org/article/10.3389/fpsyt.2018.00412/full
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!